Related Experiment Video
Updated: Jun 13, 2026
08:08
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
Published on: July 8, 2011
Optimized protocols for siRNA delivery into monocytes and dendritic cells.
Anne Mobergslien1, Mouldy Sioud
1Departments of Immunology, Institute for Cancer Research, Radiumhospitalet-Rikshopitalet University Hospital, Oslo, Norway.
Methods in Molecular Biology (Clifton, N.J.)
|April 14, 2010
Summary
Immunotherapy shows promise for cancer treatment but is hindered by immunosuppressive proteins. RNA interference (RNAi) using small interfering RNAs (siRNAs) can modulate immune cells, offering a new strategy to enhance cancer immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Immunotherapy is a promising cancer treatment, but its effectiveness is limited by immunosuppressive proteins that impair dendritic cell (DC) and T-cell functions.
- RNA interference (RNAi) offers a method to study gene function in immune cells.
- Small interfering RNAs (siRNAs) can modulate DC maturation, function, and survival by targeting immune-suppressing genes.
Purpose of the Study:
- To describe protocols for introducing siRNAs into human monocytes and DCs.
- To explore the potential of RNAi to overcome immune suppression in cancer immunotherapy.
Main Methods:
- Utilizing RNA interference (RNAi) with small interfering RNAs (siRNAs).
- Employing standard electroporation techniques.
- Introducing siRNAs into human monocytes and dendritic cells (DCs).
Main Results:
- Protocols for siRNA delivery into human monocytes and DCs are detailed.
- Demonstrates the feasibility of using siRNA to target genes involved in immune suppression within DCs.
Conclusions:
- siRNA delivery via electroporation is a viable method for modulating human monocytes and DCs.
- This technique holds potential for enhancing cancer immunotherapy by overcoming immune suppression.
